URI:
   DIR Return Create A Forum - Home
       ---------------------------------------------------------
       mortgagepro
  HTML https://mortgagepro.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: General Discussion
       *****************************************************
       #Post#: 14--------------------------------------------------
       psychedelics do have a medicinal 
       By: Muslima Akter Date: August 29, 2023, 11:01 pm
       ---------------------------------------------------------
       Free in the car? The Motorola Roadster 2 is a full-featured,
       Bluetooth speakerphone that delivers on both performance and
       ease-of-use. 3. Plantronics BackBeat Go Plantronics BackBeat Go
       The $99 Plantronics BackBeat Go is a comfortable, extremely
       unobtrusive, wireless stereo Bluetooth earphone set that works
       equally well for voice calls and music. Excellent voice quality
       and noise suppression in both directions, and the tangle-free
       cord really works. 4. Aliph Jawbone Era Aliph Jawbone Era The
       Aliph Jawbone Era is more than a headset: it's a potential audio
       computing platform. It's the first Bluetooth headset with an
       accelerometer and a dedicated applications processor, which
       could turn it into anything from a game controller to a
       pedometer, or a navigation unit. The sound quality can be just a
       touch muddy, however. 5. Logitech UE Mobile Boombox Logitech UE
       Mobile Boombox You might find louder and sharper Bluetooth
       speakers than the $99 Logitech UE Mobile Boombox, but you won't
       find a better all-around package close to its price.
       It wins our Editors' Choice award for the category. Nitpicks:
       the bass could be stronger. And the speakerphone, while clear,
       doesn't get particularly loud. Explains How to Build a Brand
       Identity That People Love INC. 5000 He Fled a Civil War at Age
       8. Now He's Driving One of the Fastest-Growing Companies in
       America INC. 5000 How a Former Union Steamfitter Brings In $17
       Million Building Out a Boomtown LEADERSHIP NOW I Want to Rebrand
       the Term 'Empty Nester,' but Elon Musk's X Offers a Cautionary
       Tale INC. 5000 Splendies' Founder Built His Brand to Sell. Then
       Came the Hard Part INC. 5000 The Key to Success? Sometimes It's
       All About Changing Your Tune BEST IN BUSINESS 5 Reasons to Apply
       for Inc.'s 2023 Best in Business Awards READ NEXT HEALTH CARE
       Psychedelics Are Reaching New Highs in Acceptance, and
       Businesses Want InOnce seen as taboo, psychedelics are being
       recognized for their medicinal potential in treating certain
       mental health ailments. But entrepreneurs in the field still
       must tread carefully. BY MELISSA ANGELL, POLICY CORRESPONDENT
       @MELISSAJOURNO A psilocybe cubensis mushroom.
       For psychedelic proponents, the past summer has been full of
       wins: The government, Congress, and individual states have all
       shown signs of growing acceptance to explore uses of these drugs
       as treatments. And as psychedelics continue to gain traction,
       more business opportunities are on the horizon. The most popular
       psychedelics that come to mind--lysergic acid diethylamide
       (LSD), psilocybin (colloquially known as magic mushrooms), DMT
       (dimethyltryptamine), and ecstasy (MDMA)--all share a Schedule 1
       drug classification, defined as drugs without medical use that
       can be easily abused. But what if use? Australia seems to think
       so: At the end of June, that nation became the first in the
       world to approve MDMA for treating posttraumatic stress disorder
       (PTSD), and psilocybin for treatment-resistant depression. In
       the U.S., these drugs have been heavily stigmatized, and the
       Schedule 1 classification also stymies research opportunities.
       That, in turn, strains grant funding. But perceptions are
       rapidly shifting, and guidance is being released for the
       evolving psychedelic market. The Food and Drug Administration
       recently released its first-ever draft guidance to provide
       clarity for conducting clinical trials for psychedelic research.
       *****************************************************